来自MSN1 天
Research Paves Way for Off-the-Shelf CAR T Cells for Cancer Treatment
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
Viral protein Nef enables a step toward off-the-shelf CAR T cell therapy for cancer
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
Medindia2 天
Qartemi: India's Affordable CAR-T Therapy for Blood Cancer
Discover Qartemi, India's innovative CAR-T cell therapy for B-cell Non-Hodgkin Lymphoma, offering personalized and affordable ...
Dog With Cancer 'Almost Back to Normal' After Pioneering New Treatment
Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...
Lab-grown T cells with altered metabolism offer lasting cancer defense
Researchers from the University of Pittsburgh have developed a new way to grow T cells in the lab that enables them to live ...
Engineering Immunity: The Breakthroughs Driving The CAR T-Cell Therapy Market (Growing At A ...
The CAR T-cell therapy market size was valued at $2.6 billion in 2022 and is estimated to reach $35.9 billion by 2032, exhibiting a CAGR of 28.5% by 2032.
manilatimes3 天
Gamma Delta T Cell Cancer Therapy Clinical Trials Overview
Global Gamma Delta T Cell Cancer Therapy Market Opportunity and Clinical Trials Insight 2030 Report Conclusions: Download ...
Peninsula biotech moves from IPO to chopping half its workforce in little more than a year
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
Targeted Oncology6 天
Novel CAR T-Cell Therapy GCC19CART Active in Refractory mCRC
Preliminary findings from the phase 1 trial showed that GCC19CART, a novel CAR T-cell therapy, demonstrated clinical ...